Evidence map›Paper›PMID 34257531›Full record

ArticlePathology oncology research : POR2021

LncRNA LINC-PINT Inhibits Malignant Behaviors of Laryngeal Squamous Cell Carcinoma Cells via Inhibiting ZEB1.

Xianguang Yang, Susheng Miao, Xionghui Mao, Cheng Xiu, Ji Sun, Rong Pei, Shenshan Jia

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathology oncology research : POR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Xianguang YangDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Susheng MiaoDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Xionghui MaoDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Cheng XiuDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Ji SunDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Rong PeiDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Shenshan JiaDepartment of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
Third Affiliated Hospital of Harbin Medical University · CNHarbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Cell Line, TumorCell MovementCell ProliferationEnhancer of Zeste Homolog 2 ProteinFemaleGene Expression Regulation, NeoplasticHumansLaryngeal NeoplasmsMaleMiddle AgedPrognosisProto-Oncogene Proteins c-aktRNA, Long NoncodingSignal TransductionSquamous Cell Carcinoma of Head and NeckTOR Serine-Threonine KinasesEnhancer of Zeste Homolog 2 ProteinEZH2 protein, humanMTOR protein, humanProto-Oncogene Proteins c-aktRNA, Long NoncodingTOR Serine-Threonine KinasesZEB1 protein, humanZinc Finger E-box-Binding Homeobox 1EZH2invasionlaryngeal squamous cell carcinomaLINC-PINTmigrationZEB1

Identifiers

PMID34257531
PMCPMC8262191
OpenAlexW3150807987

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.